New publication appeared in the International Journal of Nanomedicine about the Modulated electro-hyperthermiaPlease download the article here
Title: Modulated electro-hyperthermia-enhanced liposomal drug uptake by cancer cells
1Department of Radiation Oncology, Chiayi Christian Hospital, Chiayi, Taiwan; 2Department of Biomedical Engineering, Chung Yuan Christian University, Taoyuan, Taiwan; 3Department of Radiation Therapy and Oncology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan; 4Institute of Radiation Science and School of Medicine, National Yang-Ming University, Taipei, Taiwan; 5Department of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan; 6Institute of Molecular Medicine and Bioengineering, National Chiao Tung University, Hsinchu, Taiwan; 7Institute of Veterinary Clinical Science, School of Veterinary Medicine, National Taiwan University, Taipei, Taiwan; 8School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan
Modulated electro-hyperthermia (mEHT) stands to be a significant technological advancement in the hyperthermia field, utilizing autofocusing electromagnetic power on the cell membrane to create massive apoptosis. Since mEHT possesses the unique ability to excite cell membranes, we hypothesized that mEHT could enhance the uptake of liposomal drugs by enhancing phagocytic activity.
Materials and methods:
Water bath control and mEHT were used to compare the enhancement of liposome-encapsulated doxorubicin (Lipodox®) uptake by cancer cells. Cancer cells were made visible by doxorubicin fluorescence to investigate drug uptake. Viable cell yield was determined via the Trypan Blue exclusion method. Various substrates were used to investigate the mechanism of drug-uptake enhancement. The murine colon carcinoma model, CT26, was used to confirm the tissue infiltration of Lipodox® and its therapeutic effect.
mEHT treatment showed a significant enhancement of Lipodox® uptake of doxorubicin fluorescence compared with 37°C or 42°C water bath treatment. Tumor tissue sections also confirmed that mEHT treatment achieved the highest doxorubicin concentration in vivo (1.44±0.32 μg/g in mEHT group and 0.79±0.32 μg/g in 42°C water bath). Wortmannin was used to inhibit the macropinocytosis effect and 70 kDa dextran-FITC served as uptake substance. The uptake of dextran-FITC by cancer cells significantly increased after mEHT treatment whereas such enhancement was significantly inhibited by wortmannin.
The result showed mEHT-induced particle-uptake through macropinocytosis. mEHT-enhanced uptake of Lipodox® may amplify the therapeutic effect of liposomal drugs. This novel finding warrants further clinical investigation.
hyperthermia, cancer treatment, liposome, doxorubicin, micropinocytosis